Predictive Value of the Tuberculin Skin Test among Newly Arriving Immigrants

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Mulder, Christiaan ^a,b   Mulleners, Brigit ^a   Borgdorff, Martien W ^b,c   van Leth, Frank ^a,b  

^a KNCV TUBERCULOSIS FOUNDATION   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c DEPARTMENT OF INFECTIOUS DISEASES   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE COURSE; FEMALE; HIGH RISK POPULATION; HUMAN; IMMIGRANT; INFECTION RISK; INTERFERON GAMMA RELEASE ASSAY; LATENT TUBERCULOSIS; MALE; NETHERLANDS; NORMAL VALUE; PREDICTIVE VALUE; SCREENING TEST; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST; TUBERCULOSIS;

ADOLESCENT; ADULT; COHORT STUDIES; DISEASE PROGRESSION; EMIGRANTS AND IMMIGRANTS; FEMALE; HUMANS; MALE; MASS SCREENING; PREDICTIVE VALUE OF TESTS; REAGENT KITS, DIAGNOSTIC; TUBERCULIN TEST; TUBERCULOSIS; YOUNG ADULT;

EID: 84875457361     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060130     Document Type: Article

References (21)

1. KNCV Tuberculosis Foundation (2010) Tuberculose in Nederland 2010 [Tuberculosis in The Netherlands 2010].
2. Greenaway C, Sandoe A, Vissandjee B, Kitai I, Gruner D, et al. (2011) Tuberculosis: evidence review for newly arriving immigrants and refugees. Cmaj 183: E939-951.
3. Bwire R, Nagelkerke N, Keizer ST, Annee-van Bavel J, Sijbrant J, et al. (2000) Tuberculosis screening among immigrants in The Netherlands: what is its contribution to public health? Neth J Med 56: 63-71.
4. Pai M, Dheda K, Cunningham J, Scano F, O'Brien R, (2007) T-cell assays for the diagnosis of latent tuberculosis infection: moving the research agenda forward. Lancet Infect Dis 7: 428-438.
5. Mulder C, van Deutekom H, Huisman EM, Toumanian S, Koster BF, et al. (2012) Role of Quantiferon-TB Gold In-Tube in screening new immigrants for tuberculosis infection. Eur Respir J 40: 1443-1449.
6. Kik SV, Franken WP, Mensen M, Cobelens FG, Kamphorst M, et al. (2010) Predictive value for progression to tuberculosis by IGRA and TST in immigrant contacts. Eur Respir J 35: 1346-1353.
7. Mahomed H, Hawkridge T, Verver S, Abrahams D, Geiter L, et al. (2011) The tuberculin skin test versus QuantiFERON TB Gold(R) in predicting tuberculosis disease in an adolescent cohort study in South Africa. PLoS One 6: e17984.
8. Prentice RL, (1986) A case-cohort design for epidemiologic studies and disease prevention trials. Biometrika 73: 1-11.
9. Vynnycky E, Fine PE, (2000) Lifetime risks, incubation period, and serial interval of tuberculosis. Am J Epidemiol 152: 247-263.
10. Diel R, Loddenkemper R, Meywald-Walter K, Niemann S, Nienhaus A, (2008) Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. Am J Respir Crit Care Med 177: 1164-1170.
11. Winje BA, Oftung F, Korsvold GE, Mannsaker T, Jeppesen AS, et al. (2008) Screening for tuberculosis infection among newly arrived asylum seekers: comparison of QuantiFERONTB Gold with tuberculin skin test. BMC Infect Dis 8: 65.
12. Hill PC, Jackson-Sillah DJ, Fox A, Brookes RH, de Jong BC, et al. (2008) Incidence of tuberculosis and the predictive value of ELISPOT and Mantoux tests in Gambian case contacts. PLoS One 3: e1379.
13. Torres Costa J, Silva R, Sa R, Cardoso MJ, Nienhaus A, (2010) Serial testing with the interferon-gamma release assay in Portuguese healthcare workers. Int Arch Occup Environ Health 84: 461-469.
14. Harstad I, Jacobsen GW, Heldal E, Winje BA, Vahedi S, et al. (2010) The role of entry screening in case finding of tuberculosis among asylum seekers in Norway. BMC Public Health 10: 670.
15. Smieja MJ, Marchetti CA, Cook DJ, Smaill FM (2000) Isoniazid for preventing tuberculosis in non-HIV infected persons. Cochrane Database Syst Rev: CD001363.
16. Lobue P, Menzies D Treatment of latent tuberculosis infection: An update. Respirology 15: 603-622.
17. Nienhaus A, Schablon A, Torres Costa J, Diel R, (2011) Systematic review of cost and cost-effectiveness of different TB-screening strategies. BMC Health Serv Res 11: 247.
18. Pooran A, Booth H, Miller RF, Scott G, Badri M, et al. (2010) Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis. BMC Pulm Med 10: 7.
19. Abdalhamid B, Hinrichs SH, Garrett JL, O'Neill JM, Hansen-Cain KM, et al. (2010) Utilization of the QuantiFERON-TB Gold Test in a 2-Step Process with the Tuberculin Skin Test to Evaluate Healthcare Workers for Latent Tuberculosis. J Clin Microbiol 48: 2955-2956.
20. Grinsdale JA, Ho CS, Banouvong H, Kawamura LM, (2011) Programmatic impact of using QuantiFERON((R))-TB Gold in routine contact investigation activities. Int J Tuberc Lung Dis 15: 1614-1620.
21. Shah M, Dipietro D, Greenbaum A, Ketemepi S, Martins-Evora M, et al. (2012) Programmatic Impact of QuantiFERON-TB Gold In-Tube Implementation on Latent Tuberculosis Diagnosis and Treatment in a Public Health Clinic. PLoS One 7: e36551.